Biotech Rally Gets $100 Billion M&A Lift With More Deals to Come
A rash of dealmaking helped reverse the declining fortunes of biotech stocks over the last five months. And as AstraZeneca…
£68,063
-50,07%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca: Rating gesenkt
Frankfurt (www.aktiencheck.de) - Rating-Update:
Die Analysten von ODDO BHF stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG,…
Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
AstraZeneca will acquire Amolyt Pharma for up to $1.05 billion in total consideration…
AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare diseases portfolio By Reuters
AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare diseases portfolio…
AstraZeneca to acquire Amolyt
14 March, 2024
AstraZeneca to acquire Amolyt Pharma,
expanding late-stage rare disease pipeline
Amolyt development portfolio includes Phase III asset with potential to address…